FDA Drug recall D-1492-2020
Lidocaine Patch 5%, packaged in 30-count cartons, Rx only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108, USA, D…
- FDA Drug
- Class II
- terminated
- Published 2020-08-19
On 2020-08-19 the FDA classified a Class II recall of Lidocaine Patch 5%, packaged in 30-count cartons, Rx only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108, USA, D… by Teva Pharmaceuticals Usa, citing labeling: Incorrect or Missing Lot and/or Exp date on the individual transdermal pouches but not in the carton.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1492-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2020-07-14 |
| Published | 2020-08-19 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Teva Pharmaceuticals Usa |
| Distribution | US |
Product
Lidocaine Patch 5%, packaged in 30-count cartons, Rx only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA, NDC 0591-3525-30
Reason
Labeling: Incorrect or Missing Lot and/or Exp date on the individual transdermal pouches but not in the carton.
Identifiers
| ndc | 0591-3525-11 |
|---|---|
| ndc | 0591-3525-30 |
| code_info | Carton Lot # 1383513B, Patch Lot # 1383513, Exp date 03/2022 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1492-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.